CellProthera

Content by CellProthera

An illustration of cells flowing through a blood vessel and entering the heart, representing cell therapy for myocardial infarction

| 3 min read

CellProthera begins long-term observational study to demonstrate safety and efficacy of ProtheraCytes® cell therapy in acute myocardial infarction

The long-term PERFECT observational study follows patients from successful Phase I/IIb of ProtheraCytes for the repair and regeneration of damaged cardiac tissues after severe heart attack.

Industry Perspectives

Page 1 of 1 - 1 Total Items

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Close-up of a scientist’s hands typing on a laptop next to a microscope in a laboratory setting.

A scientist's guide to electronic laboratory notebook selection

Explore how a needs-driven approach to electronic laboratory notebook selection can improve data integrity, reproducibility, and scientific continuity.

Articles